Seeing Is Believing: A Gene Therapy First
23 mai 2018 13h18 HE
|
Ligandal Inc
SAN FRANCISCO, May 23, 2018 (GLOBE NEWSWIRE) -- For the first time, a ligand-targeted nanoparticle has been successfully used to deliver CRISPR into the nucleus of a T-cell. “From the start, CRISPR...
Ligandal CEO Unveils Nanotech Delivery for Genetic Therapies: “What Good Would Amazon Be Without the Shipping?”
07 févr. 2018 20h08 HE
|
Ligandal Inc
SAN DIEGO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cures for sickle cell, hemophilia and a host of other genetic-based diseases are on the horizon because of nanotechnology that can now deliver CRISPR,...